|
|
|
Clinical trial DesignsFMD is positioned to help our customer develop a protocol that would take into account differences in regulatory environment and treatment modality among different countries. Founders of FMD have hand-on experiences in developing protocols from Phase I to Phase IIIb in both US and China, and in major therapeutic areas including CNS, Oncology, metabolic and Cardiovascular diseases. FMD would also help our clients in revising an existing protocol developed outside of China to make it implementable in China and be compliant with Chinese regulations. |
Fountain will exhibit at both ASCO and DIA Annual Meetings next month